Hepatogenous diabetes in liver cirrhosis: a survey of awareness in an expert collective and a study of medical treatment, frequency of cirrhosis-related and diabetes-induced seque…

Aims: Hepatogenous diabetes (HD) is frequently prevalent in liver cirrhosis (LC) and represents an important prognostic risk factor for decreased long-term survival and an increased rate of several complications. Thus, compared with other complications of LC it is often overlooked in everyday practice. Furthermore, HD represents a different therapeutical entity than type 2 diabetes due to the large spectrum of contraindications for several anti-diabetic drugs in the presence of cirrhosis. However, investigations of current practice concerning treatment are extremely sparse. Aims and Methods: (I) To evaluate the…